Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOD1 | Q9Y239 | 12/20 | 0.60 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.51 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.48 |
| ▸ | CA2 | P00918 | 1/20 | 0.46 |
| ▸ | GNPAT | O15228 | 1/20 | 0.45 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23091315 | 0.93 | NOD1 (0.54) | NOD1HDAC2SLC6A5CA2GNPAT | |
| SCHEMBL9831561 | 0.86 | NOD1 (0.62) | NOD1HDAC2SLC6A5CA2GNPAT | |
| SCHEMBL6668178 | 0.86 | NOD1 (0.62) | NOD1HDAC2SLC6A5CA2GNPAT | |
| SCHEMBL9831553 | 0.85 | NOD1 (0.75) | NOD1HDAC2SLC6A5GNPAT | |
| SCHEMBL31039943 | 0.85 | NOD1 (0.70) | NOD1HDAC2SLC6A5GNPAT | |
| SCHEMBL9831556 | 0.85 | NOD1 (0.75) | NOD1HDAC2SLC6A5GNPAT | |
| SCHEMBL30905812 | 0.84 | NOD1 (0.64) | NOD1SLC6A5FOLH1 | |
| SCHEMBL7176522 | 0.83 | NOD1 (0.58) | NOD1HDAC2SLC6A5CA2GNPAT | |
| SCHEMBL378525 | 0.83 | NOD1 (0.58) | NOD1HDAC2SLC6A5CA2GNPAT | |
| SCHEMBL7170497 | 0.83 | NOD1 (0.84) | NOD1HDAC2SLC6A5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2488208-A1 | COMPOUNDS HAVING PEPTIDES CONJUGATED TO BONE TARGETING MOIETIES AND METHODS OF MAKING AND USING THEREOF | The Governors of the University of Alberta (CA) | 2012-08-22 | — | — | EP | claimed |
| WO-2024098002-A1 | CALCIUM VOLTAGE-GATED CHANNEL AUXILIARY SUBUNIT GAMMA 1 (CACNG1) BINDING PROTEINS AND CACNG1-MEDIATED DELIVERY TO SKELETAL MUSCLE | REGENERON PHARMACEUTICALS, INC. (US) | 2024-05-10 | — | — | WO | disclosed |
| EP-3906055-A2 | MULTI-SPECIFIC PROTEIN MOLECULES AND USES THEREOF | Trio Pharmaceuticals, Inc. (US) | 2021-11-10 | — | — | EP | disclosed |
| EP-3898693-A1 | ANTI-TRANSFERRIN RECEPTOR ANTIBODIES AND USES THEREOF | Avidity Biosciences, Inc. (US) | 2021-10-27 | — | — | EP | disclosed |
| EP-3758729-A1 | IL-15 CONJUGATES AND USES THEREOF | Synthorx, Inc. (US) | 2021-01-06 | — | — | EP | disclosed |
| EP-3735252-A2 | HETERODUPLEX NUCLEIC ACID MOLECULES AND USES THEREOF | Avidity Biosciences, Inc. (US) | 2020-11-11 | — | — | EP | disclosed |
| EP-3720448-A1 | COMPOSITIONS AND METHODS OF TREATING MUSCLE ATROPHY AND MYOTONIC DYSTROPHY | Avidity Biosciences, Inc. (US) | 2020-10-14 | — | — | EP | disclosed |
| EP-3691657-A1 | NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF | Avidity Biosciences, Inc. (US) | 2020-08-12 | — | — | EP | disclosed |
| EP-3684376-A1 | NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND METHODS OF INDUCING EXON SKIPPING | Avidity Biosciences, Inc. (US) | 2020-07-29 | — | — | EP | disclosed |
| WO-2020142659-A2 | MULTI-SPECIFIC PROTEIN MOLECULES AND USES THEREOF | TRIO PHARMACEUTICALS, INC. (US) | 2020-07-09 | — | — | WO | disclosed |
| WO-2020132584-A1 | ANTI-TRANSFERRIN RECEPTOR ANTIBODIES AND USES THEREOF | AVIDITY BIOSCIENCES, INC. (US) | 2020-06-25 | — | — | WO | disclosed |
| WO-2019165453-A1 | IL-15 CONJUGATES AND USES THEREOF | Synthorx, Inc. (US) | 2019-08-29 | — | — | WO | disclosed |
| WO-2019136180-A2 | HETERODUPLEX NUCLEIC ACID MOLECULES AND USES THEREOF | AVIDITY BIOSCIENCES LLC (US) | 2019-07-11 | — | — | WO | disclosed |
| WO-2019113393-A1 | COMPOSITIONS AND METHODS OF TREATING MUSCLE ATROPHY AND MYOTONIC DYSTROPHY | AVIDITY BIOSCIENCES LLC (US) | 2019-06-13 | — | — | WO | disclosed |
| WO-2019071028-A1 | NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF | AVIDITY BIOSCIENCES LLC (US) | 2019-04-11 | — | — | WO | disclosed |
| WO-2019060775-A1 | NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND METHODS OF INDUCING EXON SKIPPING | AVIDITY BIOSCIENCES LLC (US) | 2019-03-28 | — | — | WO | disclosed |
| EP-2268673-A2 | POLYPEPTIDE-POLYMER CONJUGATES AND METHODS OF USE THEREOF | The Regents of the University of California (US) | 2011-01-05 | — | — | EP | disclosed |
| WO-2009120893-A2 | POLYPEPTIDE-POLYMER CONJUGATES AND METHODS OF USE THEREOF | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2009-10-01 | — | — | WO | disclosed |
| EP-1694347-A2 | GLYCOPEGYLATED ERYTHROPOIETIN | Neose Technologies, Inc. (US) | 2006-08-30 | — | — | EP | disclosed |
| WO-2005051327-A2 | GLYCOPEGYLATED ERYTHROPOIETIN | NEOSE TECHNOLOGIES, INC. (US) | 2005-06-09 | — | — | WO | disclosed |